The most common signs and symptoms of COVID-19 are fever, cough, and shortness of breath. Less common symptoms include nausea, muscle ache, confusion, headache, and sore throat.
Preexisting comorbid conditions that increase the likelihood of severe illness with COVID-19 include cardiovascular disease, diabetes, chronic respiratory disease, hypertension, cancer, and obesity.
It is estimated that roughly 15% of people infected with the new coronavirus will develop severe disease requiring hospitalization, and another 5% will become critically ill.
Clinical Care Toolkit Introduction
The number of deaths related to complications from COVID-19 has already exceeded 2,000 Americans per day and this number is expected to rise. As COVID-19 is a novel virus, effective treatments and vaccines that reduce mortality and decrease healthcare utilization have not been developed yet and are urgently needed. Clinicians require up-to-date resources on current recommendations and clinical trial data on emerging vaccines and treatments to improve clinical outcomes during the COVID-19 pandemic. This Clinical Care Toolkit aims to provide clinicians with the latest information on the prevention, presentation, and management of COVID-19.
Click on the links below to begin exploring the COVID FRONTLINE initiative.
- Centers for Disease Control and Prevention (CDC). Learn About Age-Related Macular Degeneration. https://www.cdc.gov/features/healthyvisionmonth/index.html. Accessed March 6, 2020.
- Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet. 2018;392(10153):1147-1159.
- American Macular Degeneration Foundation [AMDF website]. Wet Macular Degeneration. https://www.macular.org/wet-amd. Accessed March 6, 2020.
- Fine AM. Earliest symptoms caused by neovascular membranes in the macular. Arch Ophthal. 1986;104:513-514.
- National Institutes of Health (NIH)/National Eye Institute (NEI). AMD Data and Statistics. https://www.nei.nih.gov/learn-about-eye-health/resources-for-health-educators/eye-health-data-and-statistics/age-related-macular-degeneration-amd-data-and-statistics. Accessed April 1, 2020.